Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Brazil pharmaceutical marketing?
Apotex inc 219660 505 b 2 ruxolitinib?
Pembrolizumab patent expeiry data?
Difference between vyvanse and generic?
Aubagio regulatory exclusvity?

Darolutamide us nce 1 filing date?

See the DrugPatentWatch profile for Darolutamide

What does “NCE 1 filing date” mean for darolutamide?

“NCE 1” refers to the FDA New Chemical Entity (NCE) review tracking used in DrugPatentWatch.com. The “filing date” is the date the company submitted the original FDA application that triggered FDA’s NCE tracking for that new chemical entity.

Darolutamide NCE 1 filing date

Darolutamide (brand name Nubeqa) has an NCE 1 filing date of 2015-05-19 1.

Source



Other Questions About Darolutamide :

darolutamide and gastric hemorrhage darolutamide and bone pain darolutamide patent darolutamide side effects cortellis drug patent intelligence: darolutamide (nubeqa) Does darolutamide cause any hair loss side effects? What type of drug is darolutamide prescribed for?